Cargando…

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells

Emerging evidence has demonstrated that microRNAs (miRNA) play a critical role in chemotherapy-induced epithelial-mesenchymal transition (EMT) in breast cancer. However, the underlying mechanism of chemotherapy-mediated EMT has not been fully understood. To address this concern, we explored the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qingling, Wang, Yangyang, Lu, Xiaohui, Zhao, Zunlan, Zhu, Lihua, Chen, Sulian, Wu, Qiong, Chen, Changjie, Wang, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413652/ https://www.ncbi.nlm.nih.gov/pubmed/25605244

Ejemplares similares

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
por: Wang, Rui, et al.
Publicado: (2015)

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
por: Wu, Qiong, et al.
Publicado: (2013)

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
por: Wang, Wenrui, et al.
Publicado: (2017)

NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018)

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer
por: Tseng, Chun-Hsien, et al.
Publicado: (2011)

MiR-146b-5p/SEMA3G regulates epithelial-mesenchymal transition in clear cell renal cell carcinoma
por: Tang, Mengxi, et al.
Publicado: (2023)

miR‐25‐3p reverses epithelial‐mesenchymal transition via targeting Sema4C in cisplatin‐resistance cervical cancer cells
por: Song, Jing, et al.
Publicado: (2016)

MiR‐138 inhibits cell proliferation and reverses epithelial‐mesenchymal transition in non‐small cell lung cancer cells by targeting GIT1 and SEMA4C
por: Li, Jiefang, et al.
Publicado: (2015)

N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma
por: Yang, Qingling, et al.
Publicado: (2017)

MiR-125b Suppression Inhibits Apoptosis and Negatively Regulates Sema4D in Avian Leukosis Virus-Transformed Cells
por: Ren, Chaoqi, et al.
Publicado: (2019)

Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1α Accumulation via Increased Production of Reactive Oxygen Species
por: Ma, Jia, et al.
Publicado: (2013)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

miR-125b inhibited epithelial–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7
por: Hong, Liquan, et al.
Publicado: (2016)

miR-125a-5p reverses epithelial-mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer
por: Li, Dongmei, et al.
Publicado: (2021)

Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial–mesenchymal transition in renal tubular epithelial cells
por: Zeng, Rui, et al.
Publicado: (2011)

Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p
por: Wang, Mei, et al.
Publicado: (2018)

The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1
por: Wu, Haihua, et al.
Publicado: (2018)

miR-125a-5p inhibits colorectal cancer cell epithelial–mesenchymal transition, invasion and migration by targeting TAZ
por: Tang, Lei, et al.
Publicado: (2019)

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
por: Lu, Yuhua, et al.
Publicado: (2014)

Knockdown of circ_0001883 may inhibit epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-125-5p/PI3K/AKT axis
por: Chen, Fu, et al.
Publicado: (2021)

Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo
por: Zhang, Shiwen, et al.
Publicado: (2023)

MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Hirao, Akihiro, et al.
Publicado: (2021)

VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
por: Chen, Ying, et al.
Publicado: (2018)

MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer
por: Zhang, Tianbiao, et al.
Publicado: (2020)

MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells
por: Zhang, Lihua, et al.
Publicado: (2013)

Sema6B, Sema6C, and Sema6D Expression and Function during Mammalian Retinal Development
por: Matsuoka, Ryota L., et al.
Publicado: (2013)

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
por: Ma, Jia, et al.
Publicado: (2015)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer
por: Yu, Jingshuang, et al.
Publicado: (2014)

Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer
por: Wang, Wenrui, et al.
Publicado: (2018)

Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells
por: Chen, Linjie, et al.
Publicado: (2018)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015)

Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial–mesenchymal transition by regulating HIF-1α via miR-138
por: Cai, Qiang, et al.
Publicado: (2017)

WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition
por: Ye, Danli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9paao47cblftp8eb7p2ue2trc0